Changing ideas on chloroquine in Plasmodium falciparum

Current Opinion in Infectious Diseases

Volumn 13, Issue 6, 2000, Pages 653-658

  Sanchez, Cecilia P ^a   Lanzer, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HEMATIN; HEME; HEMOZOIN;

ANTIMALARIAL ACTIVITY; CRYSTALLIZATION; DRUG INHIBITION; DRUG MECHANISM; HUMAN; MALARIA; PEROXIDATION; PLASMODIUM FALCIPARUM; PROTEIN DEGRADATION; REVIEW;

EID: 0033668413     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200012000-00013     Document Type: Review

References (42)

1. World malaria situation in 1994, Part I. Population at risk
2. Mechanisms of drug-resistance in malaria
3. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs
4. The fate of ferriprotoporphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs
5. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials
6. The iron environment in heme and heine-antimalarial complexes of pharmacological interest
7. Structural specificity of chloroquine-hematin binding relates to inhibition of hematin polymerization and parasite growth
8. Characterization of the products of heme detoxification pathway in malaria late trophozoites by X-ray diffraction
9. The structure of malaria pigment β-haematin
10. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials
11. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
12. A comparison and analysis of several ways to promote haematin (haem) polymerization and an assessment of its initiation in vitro
13. An integrated model of chloroquine action
14. Flavins and flavoenzymes in diagnosis and therapy
15. Heme metabolism of Plasmodium is a major antimalarial target
16. Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase
17. Kinetic modeling of chloroquine uptake by malaria-infected erythrocytes: Assessment of the factors that may determine drug resistance
18. Are ion-exchange processes central to understanding drug-resistance phenomena?
19. Chloroquine uptake, altered partitioning and the basis of drug resistance: Evidence for chloride-dependent ionic regulation
20. Identification of a chloroquine importer in Plasmodium falciparum: Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype
21. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum
22. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum
23. Chloroquine uptake and activity is determined by binding to ferriprotoporphyrin IX in Plasmodium falciparum
24. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
25. Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia
26. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand
27. Strong association, but incomplete correlation, between chloroquine resistance and allelic variation in the pfmdr-1 gene of Plasmodium falciparum isolates from India
28. Association of cg2 and pfmdr1 genotype with chloroquine resistance in field samples of Plasmodium falciparum from Nigeria
29. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand
30. Two mutations in the multidrug-resistance gene homologue of Plasmodium falciparum, pfmdr1, are not useful predictors of in vivo or in vitro chloroquine resistance in southern Africa
31. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin
32. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
33. Complex polymorphisms in an ~330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa
34. Chloroquine resistance in Plasmodium falciparum and polymorphism of the CG2 gene
35. Rapid detection of CG2 polymorphisms in chloroquine-resistant and -sensitive isolates of Plasmodium falciparum
36. Chloroquine-resistant isolates of Plasmodium falciparum with alternative CG2 omega repeat length polymorphisms
37. In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity
38. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane
39. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum
40. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance
41. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum
42. Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7